CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Abbvie - ABBV CFD

145.08
0.35%
0.66
最低: 144.68
最高: 146.42
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.66
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.030779%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.013666%
隔夜费时间 22:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Abbvie Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 144.58
开盘价* 145.74
1 年变化* 5.11%
日范围* 144.68 - 146.42
52 周范围 134.09-175.91
平均交易量(10 天) 5.61M
平均交易量(3 个月) 111.37M
市值 256.78B
市盈率 19.34
流通股 1.77B
收入 57.82B
EPS 7.51
股息(收益率 %) 4.07714
贝塔 0.60
下一个财报发布日期 Feb 9, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Feb 3, 2023 145.08 0.04 0.03% 145.04 146.64 144.53
Feb 2, 2023 144.58 -0.57 -0.39% 145.15 145.42 143.25
Feb 1, 2023 146.42 0.55 0.38% 145.87 147.28 144.87
Jan 31, 2023 147.60 2.08 1.43% 145.52 147.69 144.20
Jan 30, 2023 145.53 0.04 0.03% 145.49 146.97 144.87
Jan 27, 2023 146.10 -0.85 -0.58% 146.95 147.39 145.87
Jan 26, 2023 146.87 -0.30 -0.20% 147.17 148.53 146.87
Jan 25, 2023 147.65 1.63 1.12% 146.02 147.72 146.02
Jan 24, 2023 147.16 -0.41 -0.28% 147.57 148.55 146.25
Jan 23, 2023 147.93 -1.63 -1.09% 149.56 149.74 147.90
Jan 20, 2023 149.52 1.45 0.98% 148.07 149.57 146.87
Jan 19, 2023 148.50 0.32 0.22% 148.18 150.37 147.10
Jan 18, 2023 149.01 -2.52 -1.66% 151.53 152.26 148.63
Jan 17, 2023 152.50 -0.59 -0.39% 153.09 154.93 152.24
Jan 13, 2023 153.47 1.61 1.06% 151.86 153.67 151.30
Jan 12, 2023 151.67 -3.04 -1.96% 154.71 154.95 151.50
Jan 11, 2023 156.65 -2.32 -1.46% 158.97 158.97 154.86
Jan 10, 2023 159.46 -2.40 -1.48% 161.86 162.23 158.13
Jan 9, 2023 161.43 -3.37 -2.04% 164.80 166.05 160.72
Jan 6, 2023 166.40 3.13 1.92% 163.27 167.95 163.27

Abbvie Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
总收入 25638 28216 32753 33266 45804 56197
收入 25638 28216 32753 33266 45804 56197
收入成本,共计 5814 7158 7557 7606 15257 17314
毛利 19824 21058 25196 25660 30547 38883
总营业费用 16254 18624 26370 20283 34441 38273
销售/一般/行政费用,总计 5855 6275 7399 6942 11299 11996
研究与开发 4366 4982 5229 5407 6181 6982
利息费用(收入) - 净运营 -20 -118 161 -167
异常费用(收入) 239 327 5524 505 1704 1549
Other Operating Expenses, Total 0 500 -10 0 432
营业收入 9384 9592 6383 12983 11363 17924
利息收入(费用),非经营净值 -1268 -1442 -1168 -1551 -2351 -2435
其他,净值 -232 -423 -18 -3006 -5614 -2500
税前净收入 7884 7727 5197 8426 3398 12989
税后净收入 5953 5709 5773 7882 4622 11549
未计算非常项目前的净收益 5953 5709 5773 7882 4616 11542
净收入 5953 5309 5687 7882 4616 11542
Total Adjustments to Net Income -30 -26 -30 -40 -60 -74
普通股股东可获收益 (不含非经常性项目) 5923 5683 5743 7842 4556 11468
普通股股东可获收益 (含非經常性項目) 5923 5283 5657 7842 4556 11468
摊薄净收入 5923 5283 5657 7842 4556 11468
摊薄后加权平均股 1631 1603 1546 1484 1673 1777
扣除特别项目的每股摊薄盈利 3.63151 3.54523 3.71475 5.28437 2.72325 6.45357
Dividends per Share - Common Stock Primary Issue 2.28 2.56 3.59 4.28 4.72 5.2
每股正常摊薄盈利 3.77219 3.94326 6.27662 5.75749 3.65923 7.31817
非常规项目总计 -400 -86
少数股东权益 -6 -7
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
总收入 13010 13959 14342 14886 13538
收入 13010 13959 14342 14886 13538
收入成本,共计 4192 4498 4344 4280 4021
毛利 8818 9461 9998 10606 9517
总营业费用 8907 9518 10036 9812 8821
销售/一般/行政费用,总计 2775 3077 2977 3167 3057
研究与开发 1731 1784 1655 1812 1488
异常费用(收入) 209 227 560 553 255
Other Operating Expenses, Total 0 -68 500 0
营业收入 4103 4441 4306 5074 4717
利息收入(费用),非经营净值 -631 -620 -597 -587 -564
其他,净值 395 -2658 -21 -216 776
税前净收入 3867 1163 3688 4271 4929
税后净收入 3555 769 3180 4045 4493
少数股东权益 -2 -3 -1 -1 -3
未计算非常项目前的净收益 3553 766 3179 4044 4490
净收入 3553 766 3179 4044 4490
Total Adjustments to Net Income -17 -17 -21 -21 -22
普通股股东可获收益 (不含非经常性项目) 3536 749 3158 4023 4468
普通股股东可获收益 (含非經常性項目) 3536 749 3158 4023 4468
摊薄净收入 3536 749 3158 4023 4468
摊薄后加权平均股 1776 1776 1777 1780 1778
扣除特别项目的每股摊薄盈利 1.99099 0.42173 1.77715 2.26011 2.51294
Dividends per Share - Common Stock Primary Issue 1.3 1.3 1.3 1.3 1.41
每股正常摊薄盈利 2.12203 0.52661 2.08542 2.56798 2.68011
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
流动资产总额 16187 21223 16945 49519 24173 27928
现金和短期投资 6423 9789 8061 39924 8479 9830
现金等价物 5100 9303 7289 39924 8449 9746
短期投资 1323 486 772 0 30 84
应收账款总额,净额 4758 5088 5384 5428 8822 9977
Accounts Receivable - Trade, Net 4758 5088 5384 5428 8822 9977
Total Inventory 1444 1605 1605 1813 3310 3128
Prepaid Expenses 3337 4718 1763 2332 3562 4993
Other Current Assets, Total 225 23 132 22
Total Assets 66099 70786 59352 89115 150565 146529
Property/Plant/Equipment, Total - Net 2604 2803 2883 3306 6143 5872
Property/Plant/Equipment, Total - Gross 7526 8071 8396 8532 11754 11489
Accumulated Depreciation, Total -4922 -5268 -5513 -5226 -5611 -5617
Goodwill, Net 15416 15785 15663 15604 33124 32379
Intangibles, Net 28897 27559 21233 18649 82876 75951
Long Term Investments 1783 2090 1420 93 293 277
Other Long Term Assets, Total 1212 1326 1208 1944 3956 4122
Total Current Liabilities 9781 16641 17239 15585 28661 35194
Accounts Payable 1407 1474 1546 1452 2276 2882
Payable/Accrued 3375 3628 4026 3128 6516 7057
Accrued Expenses 3531 3832 4726 5423 9032 10217
Notes Payable/Short Term Debt 377 400 3699 0 34 14
Current Port. of LT Debt/Capital Leases 25 6015 1609 3753 8468 12481
Other Current Liabilities, Total 1066 1292 1633 1829 2335 2543
Total Liabilities 61463 65689 67798 97287 137489 131121
Total Long Term Debt 36440 30953 35002 62975 77554 64189
Long Term Debt 36440 30953 35002 62955 77533 64164
Deferred Income Tax 6890 2490 1067 1130 3646 3009
Other Liabilities, Total 8352 15605 14490 17597 27607 28701
Total Equity 4636 5097 -8446 -8172 13076 15408
Common Stock 18 18 18 18 18 18
Additional Paid-In Capital 13678 14270 14756 15193 17384 18305
Retained Earnings (Accumulated Deficit) 4378 5459 3368 4717 1055 3127
Treasury Stock - Common -10852 -11923 -24108 -24504 -2264 -3143
Unrealized Gain (Loss) 46 0 -10 0 0
Other Equity, Total -2632 -2727 -2470 -3596 -3117 -2899
Total Liabilities & Shareholders’ Equity 66099 70786 59352 89115 150565 146529
Total Common Shares Outstanding 1592.51 1592.13 1478.82 1478.91 1765.13 1768.34
Capital Lease Obligations 20 21 25
Minority Interest 21 28
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流动资产总额 26569 25999 28957 27928 26509
现金和短期投资 9777 8600 12249 9830 7572
现金等价物 9755 8546 12182 9746 6098
短期投资 22 54 67 84 1474
应收账款总额,净额 9588 9914 9281 9977 10733
Accounts Receivable - Trade, Net 9588 9914 9281 9977 10733
Total Inventory 3272 3386 3094 3128 3483
Prepaid Expenses 3932 4099 4333 4993 4721
Total Assets 150501 147972 148858 146529 143211
Property/Plant/Equipment, Total - Net 5193 5161 5130 5872 5075
Property/Plant/Equipment, Total - Gross 10887 10816 10803 10727 10879
Accumulated Depreciation, Total -5694 -5655 -5673 -5617 -5804
Goodwill, Net 32349 32398 32296 32379 32298
Intangibles, Net 81293 79340 77456 75951 73986
Long Term Investments 305 266 272 277 260
Other Long Term Assets, Total 4792 4808 4747 4122 5083
Total Current Liabilities 31951 28684 28533 35194 32521
Payable/Accrued 20604 20783 21861 22699 22569
Notes Payable/Short Term Debt 9 17 16 14 12
Current Port. of LT Debt/Capital Leases 11338 7884 6656 12481 9940
Total Liabilities 136791 135403 135308 131121 126928
Total Long Term Debt 74183 74237 74049 64189 63522
Long Term Debt 74183 74237 74049 64164 63522
Deferred Income Tax 3768 3661 3602 3009 2831
Minority Interest 23 25 27 28 31
Other Liabilities, Total 26866 28796 29097 28701 28023
Total Equity 13710 12569 13550 15408 16283
Common Stock 18 18 18 18 18
Additional Paid-In Capital 17712 17936 18108 18305 18731
Retained Earnings (Accumulated Deficit) 2292 740 1600 3127 5103
Treasury Stock - Common -3017 -3022 -3020 -3143 -4585
Other Equity, Total -3295 -3103 -3156 -2899 -2984
Total Liabilities & Shareholders’ Equity 150501 147972 148858 146529 143211
Total Common Shares Outstanding 1765.66 1767.03 1767.81 1768.34 1766.87
Capital Lease Obligations 25
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
净收入/起跑线 5953 5309 5687 7882 4622 11549
经营活动产生的现金 7041 9960 13427 13324 17588 22777
经营活动产生的现金 425 425 471 464 666 803
Amortization 764 1076 1294 1553 5805 7718
非现金物品 1588 3141 7101 4754 8714 4927
Cash Taxes Paid 3563 1696 35 1447 1674 3648
已付现金利息 986 1099 1215 1794 2619 2712
营运资金的变化 -1689 9 -1126 -1329 106 -1322
投资活动产生的现金 -6074 -274 -1006 596 -37557 -2344
资本支出 -479 -529 -638 -552 -798 -787
其他投资现金流量项目,总计 -5595 255 -368 1148 -36759 -1557
融资活动产生的现金 -3928 -5512 -14396 18708 -11501 -19039
融资现金流项目 -34 -246 -104 -552 -333 -674
Total Cash Dividends Paid -3717 -4107 -5580 -6366 -7716 -9261
股票的发行(报废),净额 -5765 -1156 -11941 -621 -769 -690
债务的发行(退还),净额 5588 -3 3229 26247 -2683 -8414
外汇效应 -338 29 -39 7 -5 -97
现金净变化 -3299 4203 -2014 32635 -31475 1297
Deferred Taxes -2325 -898
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 3555 4324 7504 11549 4493
Cash From Operating Activities 4877 9767 17702 22777 4908
Cash From Operating Activities 206 407 630 803 198
Amortization 2009 4008 5912 7718 1855
Deferred Taxes -28 -119 -153 -898 -194
Non-Cash Items 91 3093 4047 4927 -169
Changes in Working Capital -956 -1946 -238 -1322 -1275
Cash From Investing Activities -342 -584 -1199 -2344 -1591
Capital Expenditures -188 -383 -600 -787 -162
Other Investing Cash Flow Items, Total -154 -201 -599 -1557 -1429
Cash From Financing Activities -3174 -9058 -12701 -19039 -6972
Financing Cash Flow Items -136 -312 -458 -674 -225
Total Cash Dividends Paid -2322 -4632 -6947 -9261 -2526
Issuance (Retirement) of Stock, Net -716 -653 -634 -690 -1342
Foreign Exchange Effects -55 -28 -69 -97 7
Net Change in Cash 1306 97 3733 1297 -3648
Issuance (Retirement) of Debt, Net -3461 -4662 -8414 -2879
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.7767 155214623 2427842 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.8451 85684892 580768 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.3815 77486317 366695 2022-09-30 LOW
Capital International Investors Investment Advisor 2.5913 45827258 2672137 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 2.3615 41762005 1514157 2022-09-30 LOW
Capital Research Global Investors Investment Advisor 2.0466 36193102 9896885 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.913 33830501 3749074 2022-09-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.2483 22075712 -8732086 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0162 17970964 -182537 2021-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.9843 17407862 567443 2022-09-30 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 0.9163 16204586 -101931 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.8355 14774796 -2409811 2022-09-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7296 12903350 -230939 2022-09-30 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.713 12608487 220531 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6939 12271066 -259294 2022-09-30 LOW
Nuveen LLC Pension Fund 0.6932 12258461 -722546 2022-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.6742 11923937 -987224 2022-09-30 LOW
BofA Global Research (US) Research Firm 0.6476 11452674 -853282 2022-09-30 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.5887 10410769 -248975 2022-09-30 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 0.5451 9639899 -260891 2022-09-30 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group
+485000+

交易者

65000+

每月活跃客户

$48000000+

每月投资额

$28000000+

每月提取金额

交易計算器

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

貿易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
杠杆
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

AbbVie Company profile

关于 AbbVie Inc

艾伯维公司(AbbVie)是一家基于研究的生物制药公司。 该公司从事药品和疗法的研发、生产、商业化和销售。 艾伯维公司提供各种治疗类别的产品,包括免疫学产品,其中包括Humira、Skyrizi和Rinvoq;肿瘤学产品包括Imbruvica和Venclexta;美容学产品包括Botox Cosmetic、Juvederm Collection和其他美容学。 神经科学产品,如Botox Therapeutic、Vraylar、Duopa和Duodopa以及Ubrelvy;眼部护理产品包括Lumigan、Alphagan和Restasis;妇女健康产品包括Loestrin、Orilissa和其他妇女健康;以及其他关键产品,包括Mavyret、Creon、Lupron、Linzess和Synthroid。 公司的产品在全球范围内从AbbVie拥有的分销中心和公共仓库直接销售给批发商、分销商、政府机构、医疗保健机构和独立零售商。

Industry: Pharmaceuticals (NEC)

1 N Waukegan Rd
NORTH CHICAGO
ILLINOIS 60064
US

收入报表

  • Annual
  • Quarterly

人们也观看

XRP/USD

0.41 Price
-0.850% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 0.00334

Natural Gas

2.41 Price
-2.390% 1D Chg, %
多头隔夜费 -0.1138%
空头隔夜费 0.0796%
隔夜费时间 22:00 (UTC)
价差 0.005

BTC/USD

23,416.95 Price
-0.110% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 60.00

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
多头隔夜费 -0.0223%
空头隔夜费 0.0065%
隔夜费时间 22:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球485,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易